Data / Form D filings / PLEOPHARMA, INC.
PLEOPHARMA, INC.: Form D filings
PLEOPHARMA, INC., a pharmaceuticals company in Phoenixville, PA, filed 4 Form D notices with the SEC between 2020 and 2026. The latest, on August 10, 2026, reports $5.5 million sold of a $15 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 518 KIMBERTON RD. SUITE 339, Phoenixville, PA, 19460
- Phone
- (610) 937-2882
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1801323
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | New notice | $15,000,000 | $5,500,000 | $9,500,000 | 11 | Jul 28, 2026 | sec.gov |
| Aug 8, 2025 | New notice | $36,240,000 | $6,150,000 | $30,090,000 | 9 | Jun 23, 2025 | sec.gov |
| May 6, 2022 | New notice | $16,101,849 | $11,122,252 | $4,979,597 | 47 | May 2, 2022 | sec.gov |
| Feb 4, 2020 | New notice | Indefinite | $130,000 | 1 | Jan 27, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ginger Constantine | Executive Officer, Director | |
| Jay Constantine | Executive Officer, Director | |
| Robert Finizio | Executive Officer, Director | |
| Paul Bisaro | Director | |
| Tommy Thompson | Director | |
| Sarah Hassan | Director | |
| Brij Sharma | Director | |
| Kyle Mowitz | Director | |
| Kyle Tomlin | Director | |
| Poche Thomas | Executive Officer | |
| Daniel Cartwright | Executive Officer | |
| McInerney Timothy | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Aug 10, 2026 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what PLEOPHARMA, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.